top of page
Image by Justin Case

Vesper Bio awarded grant by The Michael J. Fox Foundation to assess sortilin inhibitors in the treatment of Parkinson’s disease.

January 2024


Phase I study underway as first volunteer dosed with VES001, a first-in-class oral treatment for Frontotemporal Dementia.

December 2023

bottom of page